Watch our featured interview on Fox Business (FBN) with Kathy Ireland. Our host, Kathy Ireland, meets with the Valor Compounding Pharmacy team to discuss the various compounded medication solutions they offer, including bioidentical hormone replacement therapy (BHRT). As the need for custom therapy options for patients increases, Valor Compounding Pharmacy works directly with physicians to offer medications tailored to meet those specific needs.
BERKELEY, Calif.–(BUSINESS WIRE)–Worldwide Business with kathy ireland® interviews Valor Compounding Pharmacy’s executive team on the pharmacy’s custom medication services and how easy it is to get started as a patient or a physician.
Specializing in niche medical disciplines, Valor has built its brand around meeting each patient’s unique needs. “One of our focus areas addresses anti-aging. We recently launched a full-service hormone testing program that allows patients to speak to a pharmacist and order the kit best suited for their needs. We then review the results and provide our recommendations to both the patient and the physician,” stated Rick Niemi, CEO and founder of Valor Compounding Pharmacy.
Valor offers bioidentical hormone replacement therapy (BHRT) starting as low as $50 per 30-day supply and supports both women’s and men’s health. Providers can prescribe BHRT for their patients easily via an online HIPAA-secure BHRT prescription form.
“Rather than prescribing traditional medications as one blanket treatment option, Integrative or Functional Medicine doctors look to us to customize hormone replacement therapy to cater to their patient’s needs,” says Christine Stephanos, Vice President and Chief Pharmacy Officer of Valor Compounding Pharmacy.
Valor Compounding Pharmacy will be featured (as sponsored content) on Sunday, May 16, 2021, at 2:30 pm PST / 5:30 pm EST on Fox Business Network (FBN). Tune in to learn more about how Valor Compounding Pharmacy is reinventing the patient and provider experience throughout the United States.
Building on layers of business principles and technology, Valor focuses on quality, efficiency, and simplicity in its back-end processes. With a primary initiative to make patients’ lives better, Valor continues to tackle the issue of pricing, a barrier for many patients when considering compounded medications. Valor approached this major issue by disrupting traditional and variable pricing models and instead introduced flat-rate pricing by compound categories.
Sherine Khalil, Vice President and Chief Business Officer of Valor Compounding Pharmacy, explains, “Valor shifts the focus to the patients’ healthcare, taking the anxiety out of the cost and shipping time.”
About Valor Compounding Pharmacy™:
Valor Compounding Pharmacy™, Inc. is a multi-state licensed 503A facility housing both sterile and non-sterile laboratories, located in Berkeley, CA. PCAB accredited, Valor is a specialized pharmacy that makes custom medications to meet the unique needs of the individual patient. Our goal is to reinvent pharmacy from a reactive vendor to a proactive partner in patient health care. We do that by optimizing turnaround time, being data-driven, and reducing patient anxiety. Our focus is on non-sterile and sterile, hazardous and non-hazardous compounded medication. We work with a network of providers, patients, health systems/institutions, telehealth, and research scientists in multiple states in the United States.
About Worldwide Business with kathy Ireland®:
Worldwide Business with kathy ireland® is a weekly half-hour show featuring global executives sharing their business insights and framing the opportunities shaping their industries. Hosted by a business mogul, Kathy Ireland interviews some of the brightest minds in business today. The show broadcasts on Fox Business Network as part of their sponsored content line up and globally on Bloomberg Television. Worldwide Business with kathy ireland® extends beyond the weekly on-air program with digital content delivered on various video platforms and across social media.
Valor Compounding Pharmacy
Marketing & Media